0001597672-26-000015
SEC filingQ1 results reflect revenue decline from lower CS sales volumes amid leadership initiatives and market softness, driving gross loss and widened operating/net losses despite positive operating cash flow.
Revenue fell 10.4% year-over-year to $319.1 million, driven primarily by lower CS sales volumes as the company executed CS leadership initiatives. This volume decline was further pressured by elevated inventory levels in the acetate market and softer demand in the ethers market, leading to decreased variable margin. Partially mitigating the revenue drop, CS average sales prices improved due to newly negotiated contracts with better pricing. CC sales volumes increased as production shifted toward commodity products in line with these strategic initiatives.
Gross profit deteriorated sharply to a -$7.6 million loss from $24.1 million profit last year, compressing the gross margin to -2.4%. The swing reflects higher costs outpacing the revenue decline, with the primary impact from reduced variable margin on lower CS volumes. Operating income worsened to a -$65.3 million loss, 332.8% below prior year's -$15.1 million, yielding an operating margin of -20.5%. This expansion of losses underscores cost pressures amid the revenue mix shift away from higher-margin CS products.
Net income reflected the profitability collapse, deepening to -$81.6 million with diluted EPS of -$1.22, compared to -$32.0 million and -$0.49 in Q1 2025—a 155.2% deterioration. Despite the substantial net loss, net cash provided by operating activities remained positive at $31.9 million, down from $39.6 million, bolstered by working capital improvements that demonstrate operational discipline.
Management commentary emphasizes commitment to disciplined capital allocation and liquidity management. The company plans to prioritize reduced capital expenditures to focus on near-term cash generation and deleveraging, while evaluating capital return options as performance and financial flexibility improve. CS volumes are expected to remain lower in 2026 as customers adjust ordering and inventory positions, with anticipated improvement over the year. This strategic repositioning, including CS pricing discipline and CC volume leverage, aims to support recovery, though execution amid market headwinds remains key.
Overall, the quarter highlights the impact of deliberate CS leadership actions and market dynamics on top-line and profitability, with cash flow resilience signaling focus on balance sheet strength.